Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium After Alcohol Withdrawal Treatment
NCT00325299Phase 4Completed
- Sponsor
- Finnish Foundation for Alcohol Studies
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of magnesium in alcoholic liver disease (ALD), sponsored by Finnish Foundation for Alcohol Studies. Status: completed.
02
Drugs
magnesium
03
Conditions
alcoholic liver disease (ALD)
Beyond the preview
Go deeper on NCT00325299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00325299.